HainsworthJ.D., BurrisH.A., ErlandJ.B.: Phase I trial of docetaxel administered by weekly infusions in patients with advanced refractory cancer. J Clin Oncol, 16: 2164–2168, 1998.
3.
LuckH.J., DonneS., GlaubitzM.: Phase I study of weekly docetaxel (Taxotere) in heavily pretreated breast cancer patients. Eur J Cancer, 33: 703a, 1997.
4.
LoefflerTM, FreundW., DrogeC.: Activity of weekly Taxotere (TXT) in patients with metastatic breast cancer. Proc Am Soc Clin Oncol, 17: 435a, 1998.
5.
HainsworthJ.D., BurrisH.A., LitcyS.: Weekly docetaxel in the treatment of elderly patients with advanced non small cell lung carcinoma: a Minnie Pearl Cancer Research Network phase II trial. Cancer, 89: 328–333, 2000.
6.
HainsworthJ.D., VokesE.E.: Docetaxel (Taxotere) in combination with radiation rherapy and the potential of weekly administration in elderly and/or poor performance status patients with advanced non small cell lung cancer. Semin Oncol, 28: 22–27, 2001.
7.
HainworthJ.D., BurrisH.A., YardleyD.A.: Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II study. J Clin Oncol, 19: 3500–3505, 2001.
8.
ScholzM.C., GuessB., BarriosF.: Low-dose single-agent docetaxel (Taxotere) is effective and well tolerated in elderly men with prostate cancer. Proc Am Soc Clin Oncol, 20: 2441a, 2001.
9.
BeerT.M., PierceW.C., LoweB.A.: Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer. Ann Oncol, 12: 1273–1279, 2001.
10.
ChunH.G., PuccioC.A., MittelmannA.: Weekly docetaxel and continuous infusion 5-fluorouracil in elderly patients with cancer of the stomach and distal esophagus. Proc Am Soc Clin Oncol, 20: 645a, 2001.
